×

This Content is Gated. Please Submit to Continue:

First Name
Last Name
Company
Thank you!
Error - something went wrong!

Alzheimer's Disease: Detecting Pro-Cognitive Effects in Clinical Drug Trials

March 23, 2015

Recorded Live November 23, 2011

In this video, we discuss the different issues that arise when selecting and implementing cognitive tests in drug trials, the use of cognition testing to make decisions at the Proof of Concept stage of development, and the new requirements for assessing cognition in CNS indications. Our guest speaker is Dr. John Harrison.

Previous
Efficient Integration of ePRO and Other eClinical Systems
Efficient Integration of ePRO and Other eClinical Systems

<p>Recorded Live October 21,2011</p>

Next
Benefits of Web-Based ePRO for Phase IV Clinical Trials
Benefits of Web-Based ePRO for Phase IV Clinical Trials

<p>Recorded Live December 12, 2011</p>